Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 May;99(18):e19964.
doi: 10.1097/MD.0000000000019964.

Case report of holocarboxylase synthetase deficiency (late-onset) in 2 Chinese patients

Zihong Xiong  1 , Guoying Zhang, Xiaoli Luo, Ning Zhang, Jing Zheng
Affiliations
Case Reports

Case report of holocarboxylase synthetase deficiency (late-onset) in 2 Chinese patients

Zihong Xiong et al. Medicine (Baltimore). 2020 May.

Abstract

Rationale: Holocarboxylase synthetase (HCLS) deficiency, especially the late-onset type, is a rare disease. Affected patients can present with irreversible metabolic acidosis and may be misdiagnosed with a glucose metabolic disorder. Prompt and correct diagnosis and treatment can reduce mortality to a great extent.

Patient concerns: We report 2 Chinese patients who were diagnosed with late-onset HCLS deficiency. The age of onset of the 2 patients was approximately 8 months. The 2 patients had skin lesions, severe profound metabolic acidosis, dyspnea, and hyperglycemia.

Diagnoses: The results of urinary and blood organic acid analysis with gas chromatography/mass spectrometry revealed multiple carboxylase deficiency. Maple syrup urine disease and diabetic ketoacidosis could not be excluded. This finding is different from those of hypoglycemic complications reported in previous reports. Human genetic analysis eventually provided a definite diagnosis.

Interventions: Prompt oral treatment with biotin dramatically corrected the metabolic imbalances of the 2 patients, and continued oral biotin therapy was essential to the improvement of their prognoses.

Outcomes: Their metabolic disorders were corrected within 48 hours. During long-term follow-up, the patients achieved developmental milestones.

Lessons: Late-onset HCLS deficiency may present with obvious hyperglycemia. Human genetic analysis eventually provided a definite diagnosis. Prompt treatment with biotin is vital to correct metabolic imbalances, and continued therapy is essential to the improving long-term prognoses. Their mutations were p.R508W and c.1088T > A, and these mutations might represent hot-spot genes in Chinese populations with HCLS deficiency. The variants c.1484T > G(p.L495*) and c.835G > T(p.E279x) are likely pathogenic, and more studies are needed to confirm these results.

PubMed Disclaimer

Conflict of interest statement

The authors have no funding and conflicts of interest to disclose.

References

    1. Wolf B. Disorders of biotin metabolism. Scriver CR, Beaudet AL, Sly WS, et a1. The Metabolic and Molecular Bases of Inherited Disease, 8th edn, New York: McGraw-Hill 2001: 3935–3962.
    1. Gravel RA. Holocarboxylase synthetase: a multitalented protein with roles in biotin transfer, gene regulation and chromatin dynamics. Mol Genet Metab 2014;111:305–6. - PubMed
    1. Cowan TM, Blitzer MG, Wolf B. Working Group of the American College of Medical Genetics (ACMG) Laboratory Quality Assurance Committee. Technical standards and guidelines for the diagnosis of biotinidase deficiency. Genet Med 2010;12:464–70. - PubMed
    1. León-Del-Río A, Valadez-Graham V, Gravel RA. Holocarboxylase synthetase: a moonlighting transcriptional coregulator of gene expression and a cytosolic regulator of biotin utilization. Annu Rev Nutr 2017;37:207–23. - PubMed
    1. Li XZ, Liu L, Sheng HY, et al. Clinical analysis and long-term follow-up of multiple carboxylase deficiency in 15 children. Chin J Appl Clin Pediatr 2014;29:590–4.

Publication types